Legal & General Group Plc - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 90 filers reported holding GALENA BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2016$8,000
-20.0%
23,2190.0%0.00%
Q2 2016$10,000
-68.8%
23,2190.0%0.00%
Q1 2016$32,000
-5.9%
23,2190.0%0.00%
Q4 2015$34,000
-2.9%
23,2190.0%0.00%
Q3 2015$35,000
-10.3%
23,2190.0%0.00%
Q2 2015$39,000
+18.2%
23,2190.0%0.00%
Q1 2015$33,000
-5.7%
23,2190.0%0.00%
Q4 2014$35,000
-28.6%
23,2190.0%0.00%
Q3 2014$49,00023,2190.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,446,469$13,616,0002.03%
Harbour Capital Advisors, LLC 78,450$196,0000.19%
SABBY MANAGEMENT, LLC 708,089$1,770,0000.10%
TENOR CAPITAL MANAGEMENT Co., L.P. 174,600$437,0000.07%
Alyeska Investment Group, L.P. 530,000$1,950,0000.05%
HIGHLAND CAPITAL MANAGEMENT LP 528,027$1,320,0000.05%
KMS FINANCIAL SERVICES, INC 118,042$295,0000.05%
Quantitative Investment Management, LLC 348,500$871,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 538,100$1,345,0000.04%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 29,675$74,0000.04%
View complete list of GALENA BIOPHARMA INC shareholders